Afatinib 표적항암치료를 시행 중인 흉막 전이된 비소세포폐암 환자의 한방치료 증례보고
A Case Report of Korean Medicine Treatment of Non-small Cell Lung Cancer with Pleural Metastasis Following Targeted Chemotherapy with Afatinib
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: The purpose of this study was to report the effect of Korean medicine on a patient with non-small cell lung cancer with pleural metastasis who had been treated with afatinib. Method: A 61-year old female patient with non-small cell lung cancer with pleural metastasis was treated with acupuncture and herbal medicines, including Yijung-tang, Haengso-tang, Samchulkunbi-tang, Paeamju-bang (Feiai zhu fang), to control various symptoms caused by afatinib. The degree of pain was assessed by a numeric rating scale (NRS) and the quality of life was determined with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core 30 (EORTC QLQ-C30) and the EORTC 13-item lung cancer-specific module (EORTC LC-13). Results: After receiving acupuncture and herbal medicines, the patient showed improvement in her back and chest pain, according to the NRS score. Similarly, the Korean medicinal treatments significantly relieved her nausea, vomiting, diarrhea, hemoptysis, and alopecia. However, the EORTC QLQ-C30 assessment suggested that Korean medicinal treatments did not significantly improve the global health status of this patient. Conclusion: Korean medicine could be useful in relieving some of the symptoms occurring after conventional afatinib treatments.
Abstract
Objective: The purpose of this study was to report the effect of Korean medicine on a patient with non-small cell lung cancer with pleural metastasis who had been treated with afatinib. Method: A 61-year old female patient with non-small cell lung cancer with pleural metastasis was treated with acupuncture and herbal medicines, including Yijung-tang, Haengso-tang, Samchulkunbi-tang, Paeamju-bang (Feiai zhu fang), to control various symptoms caused by afatinib. The degree of pain was assessed by a numeric rating scale (NRS) and the quality of life was determined with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core 30 (EORTC QLQ-C30) and the EORTC 13-item lung cancer-specific module (EORTC LC-13). Results: After receiving acupuncture and herbal medicines, the patient showed improvement in her back and chest pain, according to the NRS score. Similarly, the Korean medicinal treatments significantly relieved her nausea, vomiting, diarrhea, hemoptysis, and alopecia. However, the EORTC QLQ-C30 assessment suggested that Korean medicinal treatments did not significantly improve the global health status of this patient. Conclusion: Korean medicine could be useful in relieving some of the symptoms occurring after conventional afatinib treatments.
참고문헌 (22)
- Duffy MJ, "Tissue and Blood Biomarkers in Lung Cancer : A Review", Adv Clin Chem, 86, pp.1~21 (2018)
- Boolell V, "The Evolution of Therapies in Non-Small Cell Lung Cancer", Cancers (Basel), 7(3), pp.1815~1846 (2015)
- Zylla D, "Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer", Br J Anaesth, 2014, pp.113~
- 김소라, "이압요법이 폐암 환자의 통증과 폐암 관련 삶의 질에 미치는 영향", 한국산학기술학회논문지, 21(8), pp.75~86 (2020), 한국산학기술학회[DOI]
- 심소현, "Pembrolizumab 면역치료를 시행 중인 비소세포성 폐암환자의 한방치료 증례보고", 대한한방내과학회지, 40(4), pp.709~722 (2019), 대한한방내과학회[DOI]
- Li SG, "The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer : a systematic review and meta-analysis", PLoS One, 8(2), pp.e57604~ (2013)
- 김지혜, "재발성 비소세포성 폐암환자의 Afatinib과 삼칠충초정 병용투여 경과관찰 1례", 대한한방내과학회지, 38(1), pp.72~80 (2017), 대한한방내과학회
- 심소현, "Afatinib 복약 후 발생한 비소세포성 폐암환자의 피부독성 부작용에 대한 한방치료 1례", 대한한방내과학회지, 39(5), pp.973~983 (2018), 대한한방내과학회
- Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Quality of life research, 13(4), pp.863~868 (2004)
- Bergman B, "The EORTC QLQ-LC13 : a modular supplement to the EORTC core quality of life questionnaire(QLQ-C30)for use in lung cancer clinical trials", European journal of cancer, 30(5), pp.635~642 (1994)
- Harvey RD, "Afatinib for the treatment of EGFR mutation-positive NSCLC : A review of clinical findings", J Oncol Pharm Pract, 26(6), pp.1461~1474 (2020)
- Ding PN, "Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors : A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer", J Thorac Oncol, 12(4), pp.633~643 (2017)
- Shin HM, "A study on the Physiology of the Lung by 'Un Qi'and the clinical meaning of its Phyological Systems", Journal of Korean Medicine, 18(2), pp.5~14 (1997)
- Nasrullah N, "Automated Lung Nodule Detection and Classification Using Deep Learning Combined with Multiple Strategies", Sensors(Basel), 19(17), pp.3722~3741 (2019)
- Kasymjanova G, "The potential role for acupuncture in treating symptoms in patients with lung cancer : an observational longitudinal study", Curr Oncol, 20(3), pp.152~157 (2013)
- Hwang DY, "Sin-Jeoung Bang-Yak-Hap-Pyeon", pp.124~ (2010), Yeong-Rim-Sa
- Cheng Y, "Preventive and therapeutic effects of Jiawei Lizhong Decoction on nausea and vomiting in patients with breast cancer chemotherapy", Journal of Sichuan Traditional Chinese Medicine, 5, pp.90~91 (2013)
- Zou C, "Clinical Observation on the Treatment of Diarrhea Irritable Bowel Syndrome with Spleen Deficiency and Dampness Syndrome with Shenzhu Jianpi Decoction and Ginger-separated Moxibustion", Journal of Sichuan of Traditional Medicine, 6(3), pp.161~163 (2016)
- Heo J, "Dong-Eui Bo Gam", pp.1702~ (1994), Yeogang Press
- 임도희, "杏蘇湯 및 加味八味丸이 呼吸器 杯狀細胞로부터의 뮤신 分泌에 미치는 영향", 대한한방내과학회지, 26(1), pp.1~18 (2005), 대한한방내과학회
- Chen S, "Integrated Chinese and Western Medicine Teatment of Tumor", pp.336~341 (2001), People's Medical Publishing House
- Polanski J, "Intensity of Anxiety and Depression in Patients with Lung Cancer in Relation to Quality of Life", Adv Exp Med Biol, 1023, pp.29~36 (2018)